My Lords, I first thank the noble Baroness, Lady Greengross, and congratulate her on securing this debate on an incredibly important topic, which definitely performs above the graveyard slot it has been given on a Thursday afternoon. It has been a very useful and informative debate, and a good opportunity...

My Lords, I first thank the noble Baroness, Lady Greengross, and congratulate her on securing this debate on an incredibly important topic, which definitely performs above the graveyard slot it has been given on a Thursday afternoon. It has been a very useful and informative debate, and a good opportunity...

My Lords, I declare an interest as the CEO of the International Longevity Centre-UK, which has done quite a lot of work on the issues that we are discussing. Antimicrobial resistance poses an unprecedented threat to human health. As bacteria become resistant to antibiotics, even minor infections have the potential...

My Lords, I declare an interest as the CEO of the International Longevity Centre-UK, which has done quite a lot of work on the issues that we are discussing. Antimicrobial resistance poses an unprecedented threat to human health. As bacteria become resistant to antibiotics, even minor infections have the potential...

My Lords, I add my thanks to the noble Baroness, Lady Greengross, for introducing this debate on such an important matter.

The seriousness of this issue was stated starkly by the Chief Medical Officer, Professor Dame Sally Davies, who said that if we do not act, it is possible that we...

My Lords, I add my thanks to the noble Baroness, Lady Greengross, for introducing this debate on such an important matter.

The seriousness of this issue was stated starkly by the Chief Medical Officer, Professor Dame Sally Davies, who said that if we do not act, it is possible that we...

My Lords, I congratulate the noble Baroness on securing this debate on the risks of antimicrobial resistance, or AMR. Although it is last on the list of the short debates this afternoon, this debate follows quite nicely on from the debate we had on 22 November last year when we...

My Lords, I congratulate the noble Baroness on securing this debate on the risks of antimicrobial resistance, or AMR. Although it is last on the list of the short debates this afternoon, this debate follows quite nicely on from the debate we had on 22 November last year when we...

My Lords, I, too, thank the noble Baroness, Lady Greengross, for securing this extremely important and timely debate. I begin by declaring an interest as vice-chair of the APPG on Global Tuberculosis, and I refer noble Lords to my interests as set out in the register and my work with

notus-xml...

My Lords, I, too, thank the noble Baroness, Lady Greengross, for securing this extremely important and timely debate. I begin by declaring an interest as vice-chair of the APPG on Global Tuberculosis, and I refer noble Lords to my interests as set out in the register and my work with

notus-xml...

My Lords, I thank my noble friend Lady Greengross for securing this short debate. It may be short but it is of tremendous importance globally. AMR is widely recognised as the biggest threat we face.

Many years ago I was the first person in your Lordships’ House to have a debate...

My Lords, I thank my noble friend Lady Greengross for securing this short debate. It may be short but it is of tremendous importance globally. AMR is widely recognised as the biggest threat we face.

Many years ago I was the first person in your Lordships’ House to have a debate...

My Lords, it is a great pleasure to wind up for the Opposition and thank the noble Baroness, Lady Greengross, for an excellent contribution, which other noble Lords added

to. I want to raise two issues. One is about the use of antibiotics in animals and the other is about...

My Lords, it is a great pleasure to wind up for the Opposition and thank the noble Baroness, Lady Greengross, for an excellent contribution, which other noble Lords added

to. I want to raise two issues. One is about the use of antibiotics in animals and the other is about...

Lords question for short debate on what assessment they have made of the risks of antimicrobial resistance.

Lords question for short debate on what assessment they have made of the risks of antimicrobial resistance.

Letter dated 04/02/2016 from Ben Gummer MP to Nigel Mills MP regarding the hand hygiene debate and rates of MRSA, MSSA, C. diff and E. coli. 1 p.

Letter dated 04/02/2016 from Ben Gummer MP to Nigel Mills MP regarding the hand hygiene debate and rates of MRSA, MSSA, C. diff and E. coli. 1 p.

Annual report of the Chief Medical Officer. Volume Two, 2011: infections and the rise of antimicrobial resistance. 154 p.

Annual report of the Chief Medical Officer. Volume Two, 2011: infections and the rise of antimicrobial resistance. 154 p.

Table showing numbers of cases of MRSA bacteraemia, Clostridium difficile (CDI), and MSSA bacteraemia for England, by NHS Trust, April 2009 to March 2012. 17 p.

Table showing numbers of cases of MRSA bacteraemia, Clostridium difficile (CDI), and MSSA bacteraemia for England, by NHS Trust, April 2009 to March 2012. 17 p.

Tables showing number and percentage of deaths in care homes where a) MRSA b) C. difficile c) malnutrition d) dehydration was either the underlying cause of death or mentioned anywhere on the death certificate, 1997-2009 and the number of deaths where e) MRSA and f) C. difficile were the underlying cause of death or mentioned anywhere on the death certificate for local authority and non-local authority care homes, 1997-2009. 8 p.

Tables showing number and percentage of deaths in care homes where a) MRSA b) C. difficile c) malnutrition d) dehydration was either the underlying cause of death or mentioned anywhere on the death certificate, 1997-2009 and the number of deaths where e) MRSA and f) C. difficile were the underlying...

Tables showing number and percentage of deaths in care homes where a) MRSA b) C. difficile c) malnutrition d) dehydration was either the underlying cause of death or mentioned anywhere on the death certificate, 1997-2009 and the number of deaths where e) MRSA and f) C. difficile were the underlying cause of death or mentioned anywhere on the death certificate for local authority and non-local authority care homes, 1997-2009. 7 p.

Tables showing number and percentage of deaths in care homes where a) MRSA b) C. difficile c) malnutrition d) dehydration was either the underlying cause of death or mentioned anywhere on the death certificate, 1997-2009 and the number of deaths where e) MRSA and f) C. difficile were the underlying...

I. Table showing MRSA bloodstream infections in Berkshire NHS Trusts from 2001/02 to 2009/10. II. Table showing surgical site infections in Berkshire NHS Trusts, April 2004 to 2010. III. Table showing clostridium difficile infections in Berkshire NHS Trusts, 2004 to 2010.

I. Table showing MRSA bloodstream infections in Berkshire NHS Trusts from 2001/02 to 2009/10. II. Table showing surgical site infections in Berkshire NHS Trusts, April 2004 to 2010. III. Table showing clostridium difficile infections in Berkshire NHS Trusts, 2004 to 2010.

To ask the Secretary of State for Health how many (a) deaths from and (b) cases of (i) clostridium difficile and (ii) MRSA there have been in each region in each of the last three years.

To ask the Secretary of State for Health how many (a) deaths from and (b) cases of (i) clostridium difficile and (ii) MRSA there have been in each region in each of the last three years.

To ask the Secretary of State for Health what tests are available to detect (a) MRSA and (b) clostridium difficile infection; and by what means such tests are deployed in the NHS.

To ask the Secretary of State for Health what tests are available to detect (a) MRSA and (b) clostridium difficile infection; and by what means such tests are deployed in the NHS.

To ask the Secretary of State for Health what recent progress has been made on the deployment in the NHS of new tests for (a) MRSA and (b) clostridium difficile; and what steps he is taking to ensure the deployment in the NHS of the most accurate, rapid and cost-effective...

To ask the Secretary of State for Health what recent progress has been made on the deployment in the NHS of new tests for (a) MRSA and (b) clostridium difficile; and what steps he is taking to ensure the deployment in the NHS of the most accurate, rapid and cost-effective...

To ask the Secretary of State for Health what the rate of (a) clostridium difficile and (b) MRSA infection in (i) Bassetlaw Primary Care Trust and (ii) Nottinghamshire County Teaching Primary Care Trust was in each of the last three years for which figures are available.

To ask the Secretary of State for Health what the rate of (a) clostridium difficile and (b) MRSA infection in (i) Bassetlaw Primary Care Trust and (ii) Nottinghamshire County Teaching Primary Care Trust was in each of the last three years for which figures are available.